In an interview with Fortune’s Geoff Colvin, Novartis CEO Joseph Jimenez discusses the need to get federal spending on health care under control and how cuts would affect reimbursements and innovation in the pharmaceutical industry.
↧
In an interview with Fortune’s Geoff Colvin, Novartis CEO Joseph Jimenez discusses the need to get federal spending on health care under control and how cuts would affect reimbursements and innovation in the pharmaceutical industry.